Clinical Trials Logo

Clinical Trial Summary

The purpose of this study is to evaluate the safety and performance of the ARGOS-IO system in patients with POAG and indicated cataract surgery.


Clinical Trial Description

This prospective, open-label, multi center, single-arm clinical investigation will enroll 22 consecutive patients.

Enrollment will be temporarily halted in case a serious adverse device effect (SADE) occurs, and Data and Safety Monitoring Board (DSMB) meeting will be conducted as soon as possible. The DSMB will then recommend whether to further continue the study as planned, or whether enrollment shall be stopped. In order to provide a complete overview of the study to the DSMB, an interim analysis will be performed after half of the study population (11-14 subjects) is enrolled with a minimum follow-up of 1 month. A conclusion for safety will be made if in total no more than 2 of the total of 22 patients experience a SADE.

The primary aim of this study is to show "safety", which will be evaluated based on the percentage of subjects who experience a SADE (="non-safety"), as defined in the primary endpoints.

The study will be declared a success if the final non-safety event rate is less than 6% (type II error rate of 0.20). The calculation is based on a design optimizing the minimum expected sample size with parameters alpha=0.05, beta=0.20, p0=0.75, p1=0.94. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT02434692
Study type Interventional
Source Implandata Ophthalmic Products GmbH
Contact
Status Completed
Phase N/A
Start date May 2014
Completion date April 11, 2017

See also
  Status Clinical Trial Phase
Completed NCT01085357 - Study of an Implantable Device for Lowering Intraocular Pressure in Glaucoma Patients Undergoing Cataract Surgery N/A
Completed NCT02700984 - A Study to Assess Long-Term Safety of the CyPass Micro-Stent in Patients Completing the COMPASS Trial N/A
Recruiting NCT06016972 - Qlaris Phase 2 Study of QLS-111 in POAG and/or OHT Patients Phase 2
Completed NCT01517477 - One, Two, or Three iStents for the Reduction of Intraocular Pressure in Open-angle Glaucoma Subjects N/A
Terminated NCT01180062 - Safety Study of Latanoprost Slow Release Insert Phase 1
Terminated NCT03478293 - iStent Inject in OAG Subjects on 2 Pre-op Topical Ocular Hypotensive Medications N/A
Completed NCT01166659 - Study of CyPass Implantation In Patients With Open Angle Glaucoma Refractory to Single or Multi-agent Topical Therapy N/A
Completed NCT01252849 - Purpose of This Study is to Evaluate the Safety and Efficacy of One, Two, or Three iStents for the Reduction of Intraocular Pressure in Open-angle Glaucoma Subjects N/A
Active, not recruiting NCT00902109 - Study to Compare Standard Perimetry With the New Scotoma-Oriented Perimetry (SCOPE) Using a New Fast German Adaptive Threshold Estimation (GATE) in Glaucoma Patients N/A